Novel CAR-T for Glioblastoma Induced ‘Dramatic’ Responses in Early Trial
MedPage Today) — A new approach to chimeric antigen receptor (CAR) T-cell therapy showed promise in treating recurrent glioblastoma, according to a small phase I study.
In the first-in-human trial, three patients with recurrent glioblastoma…
Read More
0
